Domestic equity benchmarks ended marginally higher after four sessions of losses, supported by gains in metal, energy and consumer stocks. ...

Dixon Technologies' shares saw a rally despite a 36% drop in March quarter net profit. Revenue from operations increased by 2% year-on-year...

Brokerage houses remain selective on Indian equities, with Morgan Stanley maintaining an underweight call on Dixon Technologies due to PLI ...

Brokerages remain optimistic on select Indian companies, highlighting strong structural growth drivers. Nomura maintains a Buy on Dixon Tec...

Dixon Technologies shares jumped after a strong Q3 profit print, but brokerages remain divided. While Motilal Oswal stays bullish, Goldman ...

Dixon Technologies’ shares slipped, extending a four-session 7% drop despite reporting strong Q2 results, including a 72% rise in net profi...

B&K Securities has initiated a 'Buy' rating for Dixon Technologies, projecting a 25% upside, driven by India's electronics manufacturing pu...

Emkay predicts a 22% rally in Dixon Technologies shares, citing strong growth prospects, leadership in product verticals, and expansion int...

Brokerage firm Jefferies has retained its buy recommendation for IndusInd Bank and Piramal Pharma, while JP Morgan holds a neutral stance o...

Morgan Stanley maintained an underweight rating on Amara Raja with a target price of Rs 967. MS thinks that the company now matches Exide o...

Brokerage firm Jefferies maintained an underperform rating on Dixon Technologies, Nomura upgraded Apollo Tyres to neutral, Jefferies recomm...

Citigroup maintained a sell rating on Wipro post Q4 results, while UBS upgraded Voltas to buy and Investec recommended a hold on HDFC Bank ...

Jefferies maintained a hold rating on Dixon Technologies with a target price of Rs 5050. It maintained a buy on Amber Enterprises with a ta...

CLSA maintained a buy rating on Bharti Airtel with a target price of Rs 1100. Strong data subscriber additions. Postpaid subscriber acceler...

Dixon Technologies, and Amber Enterprises are incumbents while SYRMA SGS Technology, Kaynes Technology India and Avalon Technologies have b...

JPMorgan retained Ashok Leyland as overweight with a target price of Rs 175 as the company reported yet another quarter of margin beat, and...

Citigroup maintained a ‘neutral’ on Torrent Pharma with a target price of Rs 1,700. India is growing at a CAGR of 16% over the last 10 year...